Cargando…
Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials
Purpose: Treatment of chemotherapy-induced peripheral neuropathy (CIPN) is challenging for clinicians, and many clinical trials and meta-analyses on CIPN are controversial. There are also few comparisons of the efficacy among drugs used to treat CIPN. Therefore, this systematic review aimed to study...
Autores principales: | Wang, Chenkun, Chen, Si, Jiang, Weiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822574/ https://www.ncbi.nlm.nih.gov/pubmed/36618919 http://dx.doi.org/10.3389/fphar.2022.1080888 |
Ejemplares similares
-
External Treatment With Chinese Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
por: Li, Quan-yao, et al.
Publicado: (2022) -
Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
por: Han, Yaqin, et al.
Publicado: (2013) -
Antinociceptive effect of plant-based natural products in chemotherapy-induced peripheral neuropathies: A systematic review
por: Santos, Wagner Barbosa Da Rocha, et al.
Publicado: (2022) -
Efficacy of metformin in prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial
por: Bakry, Hala M., et al.
Publicado: (2023) -
Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A meta-Analysis
por: Chen, Jie, et al.
Publicado: (2021)